European Archives - Page 1500 of 1573 - European Medical Journal

Role of Nuclear Receptors in Spontaneous and Recurrent Miscarriage

Although early pregnancy loss is a common complication of human reproduction, a significant proportion of miscarriages still happen for unknown reasons.

The Epidemic of Twins: The Challenge in Obstetrics and Gynaecology

In the past 50 years, the incidence of multiple pregnancy has increased dramatically due almost exclusively to two factors: delayed childbearing and…

EMJ Reproductive Health 1.1 2015

Hello and a warm welcome to the very first edition of EMJ Reproductive Health, a brand new resource bringing you the latest developments and innovations…

‘Artificial Pancreas’ Could Revolutionise Control of Type 1 Diabetes

IMPLANTABLE ‘artificial pancreas’ may eliminate the use of insulin injections and pumps for individuals with Type 1 diabetes (T1D), potentially…

Genetic Variation Affects Potency of Anti-Diabetic Drug

EFFECTIVENESS of an anti-diabetic drug depends on small, natural differences in DNA among individuals, a discovery that has paved the way…

Thrombosis in Haematological Disorders: Tailored Management Approaches

The meeting commenced with a talk from Prof Anna Falanga on the management of thrombosis in both onco-haematological and non-oncological diseases.

Why Biosimilars Matter: An Innovative Solution to Improve Patient Access

The meeting was introduced by Prof Robin Foà who spoke about the difficulties for patients Prof Foà opened the symposium by highlighting…

Perspectives on the Treatment of Mantle Cell Lymphoma and Follicular Lymphoma in 2015 and Beyond

Prof Martin Dreyling opened the symposium by providing an overview of the current status of mantle cell lymphoma (MCL) and the current guidelines…

Relapsed/Refractory Multiple Myeloma: The Current State of Play

Multiple myeloma (MM) usually responds to treatment but is incurable. The clinical course is characterised, in most patients, by a series of remissions…

EMJ Hematology 3 [ePrint] 2015

The meeting was introduced by Prof Robin Foà who spoke about the difficulties for patients accessing therapies in the context of rising healthcare costs…